Grant: Alliance Grants
University of Western Ontario
$25,000.00
Investigating human transfer RNA variants that cause errors in protein synthesis
EF 2022-23
Résumé
All cells contain a set of transfer RNAs (tRNAs), which are molecular adaptors connecting the sequences of nucleic acids in genes to the sequences of amino acids in proteins. The aminoacyl-tRNA synthetases are responsible for ligating a specific tRNA with the correct amino acid. In all living cells, protein coding genes are transcribed into messenger RNAs (mRNAs), in which tri-nucleotide sequences, called codons, are decoded by the anticodon of the appropriate tRNA via base pairing on the ribosome to synthesize proteins of defined sequence. The new international collaboration with Dr. Todd Lowe at the University of California Santa Cruz (UCSC) will generate synergy with my lab's expertise in tRNA biology to determine how naturally occurring tRNA variants effect protein synthesis in human cells. Dr. Lowe stunned the research community by mapping human genetic variants to individual tRNA genes, revealing a diversity of tRNA mutations in our population. This project will (aim 1) characterize the ability of naturally occurring tRNA variants to cause malfunction by incorporating the wrong amino acid at a set of codons and (aim 2) determine how the regions up and down stream of tRNA genes impact expression levels. Because humans encode over 600 tRNA genes, our studies will use tRNA variants to map otherwise identical tRNA transcripts to specific tRNA genes for the first time. My lab will determine the impact of human tRNA variants on protein synthesis, while Dr. Lowe's lab will contribute state-of-the-art tRNA sequencing to precisely quantify the levels of mutant tRNAs in cells. The anticipated outcomes will contribute to a major scientific breakthrough by revealing the unexpected ability of human cells to tolerate errors in protein synthesis. Quantitation of tRNA levels is essential to determine the function of the many human tRNA genes and critical to the research objectives. Access to tRNA sequencing expertise is currently non-existent in Canada. The work will benefit Canadians by importing new and cutting-edge biotechnology to Canada and expanding fundamental knowledge about human tRNA biology in normal cells.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
580241-2022
Name nom
O'Donoghue, Patrick PM
Department département
Biochemistry
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5402
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Nucleic acids
Research subject fr
Acides nucléiques
Installment
inst:1
Partie
1
Nb partie
1
Application title
Investigating human transfer RNA variants that cause errors in protein synthesis
Application summary
All cells contain a set of transfer RNAs (tRNAs), which are molecular adaptors connecting the sequences of nucleic acids in genes to the sequences of amino acids in proteins. The aminoacyl-tRNA synthetases are responsible for ligating a specific tRNA with the correct amino acid. In all living cells, protein coding genes are transcribed into messenger RNAs (mRNAs), in which tri-nucleotide sequences, called codons, are decoded by the anticodon of the appropriate tRNA via base pairing on the ribosome to synthesize proteins of defined sequence. The new international collaboration with Dr. Todd Lowe at the University of California Santa Cruz (UCSC) will generate synergy with my lab's expertise in tRNA biology to determine how naturally occurring tRNA variants effect protein synthesis in human cells. Dr. Lowe stunned the research community by mapping human genetic variants to individual tRNA genes, revealing a diversity of tRNA mutations in our population. This project will (aim 1) characterize the ability of naturally occurring tRNA variants to cause malfunction by incorporating the wrong amino acid at a set of codons and (aim 2) determine how the regions up and down stream of tRNA genes impact expression levels. Because humans encode over 600 tRNA genes, our studies will use tRNA variants to map otherwise identical tRNA transcripts to specific tRNA genes for the first time. My lab will determine the impact of human tRNA variants on protein synthesis, while Dr. Lowe's lab will contribute state-of-the-art tRNA sequencing to precisely quantify the levels of mutant tRNAs in cells. The anticipated outcomes will contribute to a major scientific breakthrough by revealing the unexpected ability of human cells to tolerate errors in protein synthesis. Quantitation of tRNA levels is essential to determine the function of the many human tRNA genes and critical to the research objectives. Access to tRNA sequencing expertise is currently non-existent in Canada. The work will benefit Canadians by importing new and cutting-edge biotechnology to Canada and expanding fundamental knowledge about human tRNA biology in normal cells.